Evidence map›Paper›PMID 27562249›Full record

ArticleScientific reports2016

AMPK-independent inhibition of human macrophage ER stress response by AICAR.

Marcel Boß, Yvette Newbatt, Sahil Gupta, Ian Collins, Bernhard Brüne, Dmitry Namgaladze

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Marcel BoßInstitute of Biochemistry I, Goethe-University Frankfurt, Theodor-Stern-Kai 7, 60596 Frankfurt, Germany.
Yvette NewbattDivision of Cancer Therapeutics, Institute of Cancer Research, Sutton, Surrey SM2 5NG, UK.
Sahil GuptaInstitute of Biochemistry I, Goethe-University Frankfurt, Theodor-Stern-Kai 7, 60596 Frankfurt, Germany.
Ian CollinsDivision of Cancer Therapeutics, Institute of Cancer Research, Sutton, Surrey SM2 5NG, UK.
Bernhard BrüneInstitute of Biochemistry I, Goethe-University Frankfurt, Theodor-Stern-Kai 7, 60596 Frankfurt, Germany.
Dmitry NamgaladzeInstitute of Biochemistry I, Goethe-University Frankfurt, Theodor-Stern-Kai 7, 60596 Frankfurt, Germany.
Goethe University Frankfurt · DEInstitute of Cancer Research · GBFraunhofer Institute for Molecular Biology and Applied Ecology · DE

Funding

Cancer Research UK 11566
6 · The paper itself

Abstract

Obesity-associated insulin resistance is driven by inflammatory processes in response to metabolic overload. Obesity-associated inflammation can be recapitulated in cell culture by exposing macrophages to saturated fatty acids (SFA), and endoplasmic reticulum (ER) stress responses essentially contribute to pro-inflammatory signalling. AMP-activated protein kinase (AMPK) is a central metabolic regulator with established anti-inflammatory actions. Whether pharmacological AMPK activation suppresses SFA-induced inflammation in a human system is unclear. In a setting of hypoxia-potentiated inflammation induced by SFA palmitate, we found that the AMP-mimetic AMPK activator 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) potently suppressed upregulation of ER stress marker mRNAs and pro-inflammatory cytokines. Furthermore, AICAR inhibited macrophage ER stress responses triggered by ER-stressors thapsigargin or tunicamycin. Surprisingly, AICAR acted independent of AMPK or AICAR conversion to 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranosyl monophosphate (ZMP) while requiring intracellular uptake via the equilibrative nucleoside transporter (ENT) ENT1 or the concentrative nucleoside transporter (CNT) CNT3. AICAR did not affect the initiation of the ER stress response, but inhibited the expression of major ER stress transcriptional effectors. Furthermore, AICAR inhibited autophosphorylation of the ER stress sensor inositol-requiring enzyme 1α (IRE1α), while activating its endoribonuclease activity in vitro. Our results suggest that AMPK-independent inhibition of ER stress responses contributes to anti-inflammatory and anti-diabetic effects of AICAR.

Indexed as

Aminoimidazole CarboxamideAMP-Activated Protein KinasesCytokinesEndoplasmic Reticulum StressEndoribonucleasesEquilibrative Nucleoside Transporter 1HumansMacrophage ActivationMacrophagesMembrane Transport ProteinsObesityPhosphorylationProtein Serine-Threonine KinasesRibonucleotidesAICA ribonucleotideAminoimidazole CarboxamideAMP-Activated Protein Kinasescif nucleoside transporterCytokinesEndoribonucleasesEquilibrative Nucleoside Transporter 1ERN1 protein, humanMembrane Transport ProteinsProtein Serine-Threonine KinasesRibonucleotidesSLC29A1 protein, human

Identifiers

PMID27562249
PMCPMC4999824
OpenAlexW2510959360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.